Corbus Pharmaceuticals Hldgs Inc (CRBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -57,982 | -34,640 | -16,978 | -40,209 | -30,679 |
| Depreciation Amortization | -490 | -490 | -123 | -2,343 | -1,650 |
| Accounts payable and accrued liabilities | -1,785 | -509 | -684 | 1,603 | -75 |
| Other Working Capital | 5,285 | -878 | -1,000 | -5,576 | -3,026 |
| Other Operating Activity | 6,402 | 3,497 | 2,364 | 4,731 | 4,578 |
| Operating Cash Flow | $-48,570 | $-33,020 | $-16,421 | $-41,794 | $-30,852 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 55,504 | 35,866 | 18,123 | -121,310 | -130,040 |
| Investing Cash Flow | $55,504 | $35,866 | $18,123 | $-121,310 | $-130,040 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | -15,480 | -15,480 |
| Common Stock Issued | 2,851 | N/A | N/A | 182,058 | 182,071 |
| Financing Cash Flow | $2,851 | $N/A | $N/A | $166,578 | $166,591 |
| Beginning Cash Position | 17,868 | 17,868 | 17,868 | 14,394 | 14,394 |
| End Cash Position | 27,653 | 20,714 | 19,570 | 17,868 | 20,093 |
| Net Cash Flow | $9,785 | $2,846 | $1,702 | $3,474 | $5,699 |
| Free Cash Flow | |||||
| Operating Cash Flow | -48,570 | -33,020 | -16,421 | -41,794 | -30,852 |
| Free Cash Flow | -48,570 | -33,020 | -16,421 | -41,794 | -30,852 |